- Report of Foreign Issuer (6-K)
15 3월 2012 - 9:08PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND
EXCHANGE COMMISSION
Washington, D.C.
20549
______________________
FORM 6-K
Report of Foreign
Private Issuer
Pursuant to Rule 13a-16 or 15d-16
of the Securities Exchange Act of 1934
For
the month of March 2012
Commission File Number:
000-28508
Flamel Technologies
(Translation of
registrant's name into English)
Parc Club du
Moulin à Vent
33 avenue du
Dr. Georges Levy
69693 Vénissieux
Cedex France
(Address of principal
executive offices)
Indicate by check mark whether the registrant
files or will file annual reports under cover of Form 20-F or Form 40-F.
Indicate by check mark whether registrant
by furnishing the information contained in this Form is also thereby furnishing the information to the Commission pursuant to Rule
12g3-2(b) under the Securities Exchange Act of 1934.
If "Yes"
is marked, indicate below the file number assigned to the registrant in connection with Rule 12g3-2(b): 82-____________
INFORMATION
FILED WITH THIS REPORT
Document Index
99.1 Press
release regarding 2011 fourth quarter and annual results, dated March 14, 2011.
99.2 Press
release regarding acquisition of Éclat Pharmaceuticals, LLC and appointment of Michael S. Anderson as Chief Executive Officer,
dated March 14, 2011.
SIGNATURES
Pursuant to the requirements
of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned,
thereunto duly authorized.
|
Flamel Technologies, S.A.
|
|
|
|
|
|
Dated: March 15, 2012
|
By:
|
/s/ Michael S. Anderson
|
|
Name: Michael S. Anderson
|
|
Title: Chief Executive Officer
|
EXHIBIT INDEX
Exhibit Number
|
Description
|
99.1
|
Press release regarding 2011 fourth quarter and annual results, dated March 14, 2011.
|
99.2
|
Press release regarding acquisition of Éclat Pharmaceuticals, LLC and appointment of Michael S. Anderson as Chief Executive Officer, dated March 14, 2011.
|
Avadel Pharmaceuticals (NASDAQ:AVDL)
과거 데이터 주식 차트
부터 6월(6) 2024 으로 7월(7) 2024
Avadel Pharmaceuticals (NASDAQ:AVDL)
과거 데이터 주식 차트
부터 7월(7) 2023 으로 7월(7) 2024